Cancer immunotherapy drugs called immune checkpoint inhibitors take the brakes off the body’s immune system, allowing it to find and attack cancer cells. One such checkpoint protein, programmed cell ...

Durvalumab shows promising results in trial led by London-based Institute of Cancer Research ...

The Alliance for Clinical Trials in Oncology (Alliance) today announced that the U.S. Food and Drug Administration has ...

Research done right here in Nashville shows a new approach is leading to promising results in the fight against melanoma, ...

A clinical oncology research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), in collaboration with the US National Cancer Institute (NCI), has developed an innovative big ...

A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in ...

New funding from the Cancer Prevention and Research Institute of Texas (CPRIT) will help Rice University advance cancer research on several fronts, from strengthening a core genetic engineering ...

For years, cancer treatment meant the sum of three main things: surgery, chemo, and lately, immunotherapy. These have made a ...

From T cells to tumor takedowns, The ImmunoVerse™ podcast from the Moffitt Cancer Center is igniting a conversation around the visionaries and breakthroughs transforming how we treat cancer. A tumor ...

A groundbreaking study presented at the American Association for Cancer Research’s annual meeting has revealed remarkable potential for helping certain cancer patients avoid surgery through ...

Cancer immunotherapy has significantly changed the clinical management of multiple malignancies, yet substantial challenges remain in identifying which ...

Drs Ursula A. Matulonis and Gini F. Fleming discuss the state of endometrial cancer, the role of immunotherapy, and priorities for research in this field. Drs Ursula A. Matulonis and Panagiotis A.